Pharmaxis Treatment to Prevent Wound and Burns Scars Clears Phase 1 Trial
- Written by PR Newswire
- Topical treatment safe and well tolerated in study of healthy volunteers
- Full inhibition of lysyl oxidase enzymes achieved in skin with minimal systemic exposure
- Collaboration with research team led by Professor Fiona Wood AM planning for trial in patients with established scars to commence in Q4 2021
SYDNEY, Aug. 31, 2021 /PRNewswire/ -- Pharmaxis...
